%0 Journal Article
%T Hypermethylation of the 5¡ä CpG island of the p14ARF flanking exon 1¦Â in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression
%A Christine Nyiraneza
%A Christine Sempoux
%A Roger Detry
%A Alex Kartheuser
%A Karin Dahan
%J Clinical Epigenetics
%D 2012
%I BioMed Central
%R 10.1186/1868-7083-4-9
%X Detailed maps of the alterations in the p14ARF gene were determined in a cohort of 98 CRCs to detect both nucleotide and copy-number changes. Methylation-specific PCR combined with bisulfite sequencing was used to evaluate the prevalence and distribution of p14ARF methylation. p14ARF alterations were then correlated with MSI status, TP53 mutations, and immunohistochemical expression of p53 and MDM2. The frequency of p14ARF mutations was extremely low (1/98; 1%), whereas coexistence of methylated and unmethylated alleles in both tumors and normal colon mucosa was common (91/98; 93%). Only seven of ninety-eight tumors (7%) had a distinct pattern of methylation compared with normal colon mucosa. Evaluation of the prevalence and distribution of p14ARF promoter methylation in a region containing 27 CpG sites in 35 patients showed a range of methylated CpG sites in tumors (0 to 25 (95% CI 1 to 13) versus 0 to 17 (95% CI 0 to 2)) in adjacent colon mucosa (P£¿=£¿0.004). Hypermethylation of the p14ARF promoter was significantly correlated with the restricted p53 overexpression pattern (P£¿=£¿0.03), and MDM2 overexpression (P£¿=£¿0.02), independently of MSI phenotype. Although no significant correlation between p14ARF methylation and TP53 mutational status was seen (P£¿=£¿0.23), methylation involving the proximal CpG sites within the 5¡ä CpG flanking exon 1¦Â was present more frequently in tumors with restricted p53 overexpression than in those with diffuse p53 overexpression (range of methylated clones 17 to 36% (95% CI 24 to 36%) versus range 0 to 3% (95% CI 0 to 3%), P£¿=£¿0. 0003).p14ARF epigenetic silencing may represent an important deregulating mechanism of the p53-MDM2-p14ARF pathway in CRCs exhibiting a restricted p53 overexpression pattern.The correct functioning of the p53-MDM2-p14ARF pathway requires a delicate balance between the opposing effects of its different components [1-3]. Genetic and epigenetic alterations have been shown to distort this balance in various human mal
%U http://www.clinicalepigeneticsjournal.com/content/4/1/9